OncoCyte Corporation and The Wistar Institute Enter into Global Licensing AgreementGlobal Licensing Agreement • January 27th, 2016 • OncoCyte Corp • In vitro & in vivo diagnostic substances
This licensing agreement builds on existing collaborations between OncoCyte and Wistar including previously announced sponsored research agreements entered into to develop and test potential lung cancer biomarkers identified by Dr. Louise Showe. In August 2015, Wistar and OncoCyte announced an expanded agreement to continue their collaboration.
